WBMT 2025 - Symposium Faculty
WBMT Faculty
Damiano Rondelli, MD
Michael Reese Professor of Hematology
Chief, Division of Hematology/Oncology
Director, Blood & Marrow Transplant and Cell Therapy, Dept of Medicine
Director for Global Partnerships, Center for Global Health
College of Medicine
Damiano Rondelli, MD
Chicago, USA
Kuldeep Kumar Raina
Vice Chancellor Ramaiah University of Applied Sciences
Kuldeep Kumar Raina
Bengaluru, India
M.R. Jayaram
Chairman – Gokula Education Foundation and Chancellor, Ramaiah University of Applied Sciences
M.R. Jayaram
Bengaluru, India
K.B Siva Kumar, IAS
Commissioner of Health and Family Welfare Services, Karnataka
K.B Siva Kumar, IAS
Karnataka
Madan Gaekwad
Ramaiah Memorial Hospital – COO
Madan Gaekwad
Bengaluru, India
Shalini Chandrashekar Nooyi
Principal and Dean
Ramaiah Medical College
Bengaluru, India
Dr. Shalini Chandrashekar Nooyi is the Principal and Dean of MS Ramaiah Medical College, Bengaluru, India. She holds dual MD degrees in Pediatrics and Community Medicine and brings over 30 years of distinguished experience in teaching, research, and medical administration.
She began her career in Community Medicine at Manipal, focusing on Social Pediatrics in urban and rural settings, gaining valuable grassroots healthcare experience. Dr. Nooyi also contributed to non-communicable disease initiatives during her tenure with the Ministry of Health in Oman. Since joining Ramaiah Medical College in 2009, she has served in various academic roles, assuming her current leadership position since August 2022. Under her guidance, the college emphasizes nurturing well-rounded, empathetic physicians who become innovators and leaders in healthcare.
Shalini Chandrashekar Nooyi
Bengaluru, India
Dietger W Niederwieser, MD
Professor of Medicine
Conc. Professor mult; Drs. h. c.
Leipzig, Germany
Adjunct Professor
Center for Cellular Immunotheraphies
University of Pennsylvania & Penn Medicine
Philadelphia, USA
Dietger W Niederwieser, MD
Leipzig, Germany
Mahmoud Deeb Saeed M Aljurf
Professor of Medicine at Alfaisal University
Director of the Adult Stem Cell Transplantation and Cell Therapy Program and Deputy Director of the Oncology Centre
King Faisal Specialist Hospital & Research Centre
Riyadh, Saudi Arabia
Mahmoud Deeb Saeed M Aljurf
Riyadh, Saudi Arabia
Mickey B. C. Koh
Professor Mickey Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP and PhD) in London.
He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School.
He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine.
Professor Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation and sits on the Expert Committee on Biological Standardisation.
He is the current Vice-President of the Worldwide Network for Blood and Marrow Transplantation (WBMT) and a past Board member of the International Society of Cellular Therapy (ISCT). He is also on the Board of Directors for ISBT and ICCBBA, an international organisation overseeing the standard for terminology, coding and labelling of medical products of human origin.
Mickey Koh
London, UK; Singapore
Santhosh Devadas
HOD & Consultant – Department of Medical Oncology; Chief – Bone Marrow Transplant; Professor / HOD
Ramaiah Institute of Oncosciences, Ramaiah Memorial Hospital; M.S. Ramaiah Medical College & Hospital
Bengaluru (Bangalore), India
Santhosh Devadas
Bengaluru (Bangalore), India
Helen Baldomero
Contributor to Hematopoietic Stem Cell Transplantation and cellular therapy activity surveys.
WBMT Transplant Activity Survey Office – Division of Hematology, University Hospital Basel
Basel, Switzerland
Coordinater of international data collection and performance of in-depth analyses on hematopoietic stem cell transplantation and cellular therapy through the WBMT Transplant and Cellular Therapy Activity Surveys. My work focuses on ensuring analytical accuracy and transforming global data into insights that support evidence-based clinical practice, inform policy, and strengthen international research collaborations to advance transplantation and cellular therapy worldwide
Helen Baldomero
Basel, Switzerland
Laurent Garderet
Hematologist; Principal Investigator in clinical studies
Pitié-Salpêtrière University Hospital – AP-HP, Sorbonne University
Paris, France
Dr laurent Garderet is a French hematologist working in the hematology department at Pitié Salpêtrière Hospital in Paris, France. He did his medical studies as well as his training in Paris. He also did a post-doctoral internship in the transplant department of the M.D Anderson Cancer Center in Houston under the supervision of Dr Richard Champlin. His main interests focus on myeloma treatment and biology. He is a board member of the Intergroupe Francophone du Myélome and the past chairman of the Plasma Cell Disorder subcommittee of the EBMT Chronic Malignancies Working Party. He is also a member of the International Myeloma Society (IMS) as well as the International Kidney Monoclonal Gammopathy (IKMG) research group.
Laurent Garderet
Paris, France
Nina Worel
Deputy chair of the department
Specialist for Transfusion Medicine, general practitioner and emergency physician
Division management therapeutic and preparative apheresis
Head of ATMPs manufacturing
Head of tissue establishment
Responsible person tissue & cell directive
Vienna, Austria
Nina Worel
Vienna, Austria
Hildegard T. Greinix
Professor of Hematology and Oncology at the Medical University Vienna, Department of Internal Medicine I/BMT
Vienna, Austria
Hildegard T. Greinix
Vienna, Austria
Fabian Müller
Professor for CAR T cell Therapy, head of the cell therapy unit
Department of Internal Medicine 5 – Hematology and Oncology
University Hospital of Erlangen, Friedrich-Alexander-University of Erlangen Nürnberg
Prof. Müller obtained his MD in Freiburg, Germany and started his clinical education in Hamburg. Initially with a focus on targeting malignant B cells through BCR recognition, he then did his postdoc with Dr. Ira Pastan, NCI, NIH, on resistance to CD22-targeted therapy in ALL and aggressive lymphoma. After his post-doc he continued the work on B cell targeting in Erlangen, Germany using antibody directed therapies at first and then CAR T cells with a focus on translational concepts including tumor microenvironment and functional aspects of a patient’s immune system. As head of the CAR T cell unit, he pioneers CAR T cell therapies in novel indications including solid tumors and autoimmune diseases.
Fabian Müller
Saarbrücken, Germany
Anant Gokarn
Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre.
Mumbai, India
Anant Gokarn
Mumbai, India
Rizwan Javed
M.B.B.S, M.D (Path),
Fellowship (Transfusion Medicine)
MSc (Transfusion & Transplantation Sciences)
Consultant in Apheresis & Cellular therapy (manufacturing) with the Bone marrow transplant team at TATA Medical Center, Kolkata,India
Commonwealth Scholar 2017/18, trained at NHS Blood & Transplant (IBGRL), in Bristol
FACT Inspector
Kolkata, India
Rizwan Javed
Kolkata, India
Reetu Jain
Medical oncologist and BMT Physician
Director BMT and Academics
Jaslok Hospital and Research centre
Mumbai, India
Reetu Jain
Mumbai, India
Rahul Purwar
Indian Institute of Technology of Bombay
Department of Biosciences and Bioengineering
Mumbai, India
Rahul Purwar
Mumbai, India
Madhav Danthala MD, DM (Medical Oncology)
Fellowship in leukemia/BMT (UBC, Canada)
Sr. Consultant Medical Oncologist, Hemato Oncologist, & Bone Marrow Transplant Physician
Omega Hospitals, Gachibowli, Hyderabad, India
Madhav Danthala MD, DM (Medical Oncology)
Hyderabad, India
Uday Prakash Kulkarni
Christian Medical College Vellore
Vellore, Tamil Nadu, India
Uday Prakash Kulkarni
Vellore, Tamil Nadu, India
Franco Locatelli
Professor of Pediatrics at the Università Cattolica del Sacro Cuore and Head of the Department of Paediatric Haematology and Oncology and Cell and Gene Therapy at the Bambino Gesù Children’s Hospital in Rome, Italy
Franco Locatelli
Rome, Italy
Adriana Seber
Brazil
Adriana Seber
Brazil
Marco Ruella, MD
University of Pennsylvania
Philadelphia, Pennsylvania, USA
Marco Ruella, MD
Pennsylvania, USA
Prashant Mehta, MD, DM
Senior Consultant and Program Head – Lymphoid Neoplasms and Cellular Therapy
Editor-in-Chief, International Journal of Molecular and Immuno-Oncology
Hematology / Medical Oncology and Bone Marrow Transplant
Amrita Institute of Medical Sciences
Faridabad, India
Prashant Mehta, MD, DM
Faridabad, India
Sebastian Galeano
Hospital Británico
Montevideo-Uruguay
Sebastian Galeano is a member of the Hospital Británico Hematology Department-Hematopoietic Cell Transplant Program and Associate Professor of Hematology at the CLAEH University in Montevideo, Uruguay. He obtained his medical degree in 1996 and has postgraduate degrees in Internal Medicine and Hematology as well as certification in Bone Marrow Transplant from the Universidad de la República (UDELAR), Montevideo, Uruguay. He is President of the Sociedad de Hematología del Uruguay (SHU), Secretary of the Worldwide Network for Blood and Marrow Transplantation (WBMT) and Past-President of the Latin American Bone Marrow Transplantation Group (LABMT).
Sebastian Galeano
Montevideo, Uruguay
Sharat Damodar MD,DNB,DM
Clinical Director, MSMC
Chairman Oncology Collegium
Senior Consultant Haematologist and Head of Adult BMT
Mazumdar Shaw Medical Center
Bengaluru, India
Sharat Damodar MD,DNB,DM
Bengaluru, India
Christian Chabannon
Marseille, France
Prof. Christian Chabannon is a French physician, board certified in Hematology and Medical Oncology. He is a Professor of Medicine in Cell Biology at Aix-Marseille Université School of Medicine and a full member at Institut Paoli-Calmettes Comprehensive Cancer Center where he has been leading the Cell Collection and Cell Processing facilities for more than 20 years. He was a founder and head of the CBT-1409 Inserm – AMU – AP-HM – IPC, a multidisciplinary research initiative aiming at fostering development and evaluation of innovative cell and tissue -based advanced therapies in the Marseille metropolitan area. Prof. Chabannon is active in several EU professional associations, including EBMT where he served in various positions. He is a member of several national and international advisory boards. Pr Chabannon authored or co-authored more than 400 peer-reviewed publications”
Christian Chabannon
Marseille, France
Daniel Neumann
Leipzig, Germany
I am data scientist by hear. I co-founded the WBMTs eGTR and developed it to strengthen international collaboration on improving therapy using an open and scalable registry platform. I am scientific program lead on emulated target trails using real world data on drug therapy research and multi-domain therapy quality. This includes the oversight on developing a drug therapy safety research platform that enrich real world data with clinical trails documentation. I am also a researcher on complex data fusion to build up longitudinal digital twins and causal inference towards individualized targeted therapies using AI.
Daniel Neumann
Leipzig, Germany
Joseph (Yossi) Schwartz
Omaha, Nebraska, USA
Dr. Schwartz received his MD from the Technion – Israel Institute of Technology and his MPH from Columbia University Mailman School of Public Health. Upon completion of his training, he pursued a decades-long career in promoting excellence in the field of Transfusion Medicine, Apheresis & Cellular Therapy across a multitude of facilities including Columbia University Irving Medical Center, Moffitt Cancer Center and recently joined FACT as their Senior Medical Officer. In these capacities, He amounted many years of experience directing Transfusion Medicine, Apheresis & Cellular Therapy Services.
Throughout his tenure in the field, Dr. Schwartz became an active member of the professional and academic community. He had been involved in many professional organizations including AABB, CAP, ISCT, and ASCP to name few. He served as the president of ASFA in 2018-2019 and is currently the President of the World Apheresis Association. He served on the writing committee of ASFA’s Therapeutic Apheresis guidelines for five editions. Furthermore, he promoted quality and standardization through dissemination of the FACT-JACIE international standards for cellular therapy. For these efforts and many more, he Have had earned many honors including the AABB Hemphill Jordan Leadership Award (2019), ASFA’s Presidential Award (2021), Francis Morrison lectureship Award (2023), and Lecturer award (2024).
Joseph (Yossi) Schwartz
Omaha, Nebraska, USA
Koji Kato, MD, PhD
Fukuoka, Japan
Department of Medicine and Biosystemic Science
Kyushu University Graduate School of Medical Sciences
Fukuoka, Japan
Koji Kato, MD, PhD
Fukuoka, Japan
Vinayak V Maka
Bengaluru (Bangalore), India
Dr. Vinayak V Maka is a senior Oncologist who teaches and practices at the Ramaiah Medical College. He is familiar with diagnosing and treating all types of malignancies and carrying out autologous and allogeneic stem cell transplantations. Dr. Maka currently specializes in providing personalized cancer care in Gastrointestinal cancers, Urological cancers, Head and Neck cancers, Lung cancers, sarcoma, brain tumors and skin cancers. As Professor and Head Of Department for Medical Oncology, Dr. Maka and his team were instrumental in starting and securing approval for a sub specialty degree (DM) in medical oncology for students per year from 2016 and in starting the stem cell transplantation program in 2015. He has also been involved in various investigator instigated and industry driven clinical research and also has multiple research grants for translational oncology including rectal cancer stem cells in collaboration with Indian Institute of Science, Bangalore under RGUHS research Grant.
Vinayak V Maka
Bengaluru (Bangalore), India
Abhijit Baheti
Pune, India
Abhijit Baheti
Pune, India
Ana Sureda
Barcelona, Spain
Anna Sureda is a clinical hematologist internationally recognized for her expertise in hematopoietic stem cell transplantation and cellular therapies. She currently serves as Head of the Hematology Department at the Institut Català d’Oncologia (ICO) in L’Hospitalet, Barcelona, Spain, and holds an academic appointment as Associate Professor of Hematology at the University of Barcelona.
Her clinical and research interests focus on the treatment of lymphoid malignancies—particularly Hodgkin and non-Hodgkin lymphomas—through innovative transplant strategies and immunotherapeutic approaches, including CAR-T cell therapy. She has played a pivotal role in advancing supportive care and the management of transplant-related complications.
Anna Sureda has held several prominent leadership positions at both the national and international levels. Most notably, she serves as President of the European Society for Blood and Marrow Transplantation (EBMT) until 2026, after being the secretary of the society from 2010 to 2016 and chairing the society’s Lymphoma Working Party between 2004 to 2010.
Anna Sureda
Barcelona, Spain
Atharva Karulkar
Mumbai, India
Co-founder and Head-Scientific Affairs, ImmunoACT, Mumbai, India
Dr. Atharva Karulkar completed his Ph.D. in Immunology from IIT Bombay, where he focused on the mechanisms of immune response and the development of innovative therapies for cancer treatment. His academic background laid the foundation for his passion for biomedical research.
He co-founded Immuno ACT with his PhD Supervisor Dr.Rahul Purwar with the mission of advancing immunotherapeutic approaches to combat various diseases, particularly cancer. Under their leadership, the company has pioneered several groundbreaking treatments that harness the body’s immune system to fight malignancies. His work emphasizes the integration of cutting-edge technology with clinical applications, bridging the gap between research and real-world patient care.
Dr. Karulkar’s research interests include:
- Cancer immunotherapy
- Cell and gene therapy
- Personalized medicine
- Mechanisms of immune evasion by tumors
Dr. Karulkar has authored numerous peer-reviewed publications and has presented his research at international conferences. He is actively involved in collaborative projects with leading research institutions.
With a commitment to innovation and patient-centered care, Dr. Karulkar aims to transform the landscape of cancer treatment through the development of safe, effective, and accessible immunotherapies.
Atharva Karulkar
Mumbai, India
BG Dharmanand
Bengaluru, India
Consultant, RheumaCare, Bengaluru
Chronic pain – Reproductive Immunology – Autoimmunity – Bedside teaching
BG Dharmanand
Bengaluru, India
Mobin Paul
Kochi, India
Aster Medcity, Kochi (Kerala), India
Mobin Paul
Kochi, India
Nishil Gowda
Bengaluru, India
Ramaiah Medical College, Bengaluru, India
Nishil Gowda
Bengaluru, India
Rasmi Palassery
Bengaluru, India
Ramaiah Medical College, Bengaluru, India
Rasmi Palassery
Bengaluru, India
Sanish Davis
Mumbai, India
Director, R&D, GCO J&J Innovative Medicines, India and Executive committee member, Indian Society for Clinical Research (ISCR)
Mumbai, India
Sanish Davis
Mumbai, India
Satyendra Katewa
Delhi, India
Satyendra Katewa
Delhi, India
Girish Badarkhe
Senior Consultant Haematology and BMT
Girish Badarkhe
Senior Consultant Haematology and BMT
Hasmukh Jain
Medical Oncologist & Professor Tata Memorial Centre, Parel, Mumbai.
About Me: I am a medical oncologist and professor at Tata Memorial Hospital, Parel, dedicated to advancing cancer therapy and research to improve patient outcomes.
Honors and Awards: I have been privileged to receive 10 national and international honors, recognizing my contributions to oncology and patient care.
Publications: I have authored 63 publications, each aimed at expanding our understanding of cancer therapeutics and improving treatment strategies.
Ongoing Studies: I am currently involved in 15 ongoing studies focused on developing innovative therapies and enhancing survival outcomes. Also, I have contributed to 10 major research and technology development projects, reflecting my commitment to integrating innovation into clinical practice.
Teaching & Mentorship: As a professor, I find great fulfillment in mentoring the next generation of oncologists and sharing insights drawn from clinical and research experience.
Hasmukh Jain
Mumbai, India
Martin Bonamino
Brazilian National Cancer Institute and FIOCRUZ, Rio de Janeiro, Brazil.
Martin Bonamino
Rio de Janeiro, Brazil.
Rahul Bhargava
Fortis Memorial Research Institute Gurugram, Haryana, India
Rahul Bhargava
Haryana, India
Sujitha Kannan
Asst. Prof Transfusion Medicine, Ramaiah Memorial Hospital, Bengaluru, India
Sujitha Kannan
Bengaluru, India
Syed Osman Ahmed
King Faisal Specialist Hospital and Research Centre Riyadh, Saudi Arabi
Dr Ahmed completed a degree in Neuroeciences and Medicine from the Imperial college of Medicine, London, in 2000. He complained core medicine training in Medicine and attained his MRCP. He undertook specialist training in hematology and hematopoietic cell transplantation in London at Hammersmith, Royal Free and St Mary’s Hospital and number of other centres. Since 2012 he has been a consultant haematologist at the King Faisal Specialist Hospital and Research Centre with an interest in acute leukemia and transplantation and cellular therapy where he has helped establish the region’s first CAR-T program.
Syed Osman Ahmed
Riyadh, Saudi Arabia
Tanveer Ahmad
Cellogen Therapeutics New Delhi, India
Tanveer Ahmad
New Delhi, India
V. Simpson Emmanuel
Immunoadoptive Cell Therapy Private Ltd Mumbai, India
V. Simpson Emmanuel
Mumbai, India
Vikram Mathews
Director, Department of Haematology, Christian Medical College Vellore, India
Vikram Mathews
Vellore, India
Alvaro Urbano
Ispizua
Can Ruti is located in Badalona, where academia (Autonomous University of Barcelona – UAB), cutting-edge research (IJC) and health services (Hospital de Can Ruti) converge.
Graduating from the Basque Country University, Bilbao, Spain, in 1982, Alvaro Urbano-Ispizua trained in Hematology in the Postgraduate School of Hematology of Hospital Clinic of Barcelona (HCP), where in 1988 he achieved a staff post. From July 1989 to July 1990 he stayed at the Institute of Cancer Research of the University of London, analysing the role of RAS mutations and BCR/ABL oncogene in haematological diseases. During 14 years was a staff member of the Haematology Department of the HCP, being the head of the “Research Unit of Cell Therapy and Stem Cell Transplantation”. This unit is one of the pioneers of BMT in Europe. In 2007 he moved to Sevilla to lead the Department of Hematology of Hospital Virgen del Rocío. He is currently Director of the Institute of Hematology and Oncology of HCP and Full Professor of Medicine at the University of Barcelona. He is author or co-author of more than 180 articles with a Hirsch Index of 32 and more than 2400 citations. Journals in which he has published original articles include Lancet, Blood, Journal of Clinical Oncology, British Journal of Haematology, Cancer Research, Experimental Haematology, Leukaemia, Haematologica, and Bone Marrow Transplantation. Dr Urbano-Ispizua serves on the editorial board of several top journals of his specialty. His contribution to the bone marrow transplant field in Spain has been recognized by means of an official and personal communicate by the Ministry of Health, Prof. B. Soria, in 2009. He has been the General Secretary of the European Bone Marrow Transplant Group (EBMT) between 1998-2004 and the President of the Joint Accreditation Committee of EBMT and ISHAGE until October 2006. He has been private consultant of the European Commission, and has formed part of the Official panel of experts of the European Medicine Agency (EMEA).
Alvaro Urbano
Ispizua
Anoop P
Consultant Hematologist Aster Hospitals Bangalore, India
MD, DCH, FRCPCH, FRCPath (Heam), CCT (Haem)
Trained in Hematology and Pediatric Hemato-Oncology from United Kingdom
64 publications in PubMed
Expertise in malignant and benign hematological disorders in adults & children, solid tumor oncology in children, bone marrow transplantation in adults & children
Anoop P
Bangalore, India
G. Vasu Babu
Renova Century Cancer Institute, Banjara Hills, Hyderabad, India.
G. Vasu Babu
Hyderabad, India
Ganesh S Jaishetwar
Lead Consultant & Head Dept of Haematology & BMT Yashoda Hospital, Hitec City, Hyderabad
Ganesh S Jaishetwar
Hyderabad, India
Hari Menon
Professor and Head Department of Medical Oncology St Johns Medical College and Hospital, St Johns National Academy of Health Sciences Bangalore , Karnataka, India
Hari Menon
Bangalore, India
Lakshmikanth Gandikota
Chief Scientific Officer Immuneel Therapeutics Private Limited 8th Floor, Mazumdar Shaw Medical Centre, Narayana Health City, 258/1, Bommasandra Industrial Area, Bengaluru - 560099 Damon Runyon Cancer Foundation Fellow, Ph.D., M.Sc. (Gold Medallist)
An esteemed leader in the biologics, cell and gene therapy industry with over two decades of expertise in developing molecules for the US and EU markets in the biologics space. In addition to a strong background in structural, biophysical, process development, analytical, and biological assays, Lakshmikanth has demonstrated expertise in cell and gene therapy programs using AAV and Lentiviral vector-based therapies over the last eight years. He has filed several patents in the field of product development in biologics and cell and gene therapies and been a part of successful approvals of US IND’s, BLA’s and EU MAA’s for biosimilars. As the Chief Scientific Officer at Immuneel Therapeutics, Lakshmikanth oversees a team of professionals dedicated to the development of novel cell and gene therapy products and platforms. The key achievements of the same include technology transfer of antiCD19-CAR-T from HCB to Immuneel facility in India, resulting in a commercial approval of the first global CD19-CAR-T product (Qartemi®) in India, as well as successful development of a patented SIM-CAR-T platform resulting in both 3 and 7 day CAR-T product. Other notable achievements include development of an allogenic CAR-T platform and evaluation of novel humanized AntiCD19-gd CAR-T with established POC data for further studies. Prior to the current role, Lakshmikanth has served as Chief Scientific Officer of InnovaVector SRL a Gene therapy company based in Naples, Italy. He also served as Sr. Vice President, at Intas Pharmaceuticals managing R&D and Manufacturing Sciences for both Biologics and Cell and Gene therapy verticals, where he set up the R&D facility and programs for both Gene therapy and CAR-T cell therapies. Prior to that he has also served in various leadership roles in Biological Evans, Sanofi and Dr Reddy’s Laboratories.
Lakshmikanth Gandikota
Bengaluru, India
Nada Hamad
Senior Staff Specialist BMT, Clinical and Laboratory Haematologist Director of Haematology Clinical Trials Unit St. Vincents Health Network, Kinghorn Cancer Centre 370 Victoria St, Darlinghurst, NSW 2010, Australia
Professor Nada Hamad is a senior haematologist, clinician-researcher, and academic leader with expertise in bone marrow transplantation and cellular therapies. She is the current President of the Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) society and a 2025 Fulbright Senior Scholar.
Her research focuses on improving access and outcomes in advanced therapies, including CAR-T and allogeneic transplant, with a strong emphasis on equity, real-world data, and health system innovation. She leads national and international collaborations that integrate clinical care, research, and policy to address disparities in complex care.
Prof Hamad supervises ILP, Honours, and HDR students across projects spanning translational haematology, equity in access to care, and system-level reform. She is committed to mentorship, capacity building, and supporting the next generation of clinician-scientists.
Her work is supported through government, philanthropic, and industry partnerships aimed at driving meaningful change in health outcomes and health equity.
Nada Hamad
Australia
Nikhil M. Kumar
Consultant – Clinical Hematology, Hemato-Oncology and BMT Rajagiri Hospital, Kochi
Professor Nada Hamad is a senior haematologist, clinician-research
Dr. Nikhil M. Kumar is a consultant hematologist in the Department of Hematology and Bone Marrow Transplant at Rajagiri Hospital. He completed his MBBS from St. John’s Medical College, Bangalore, MD in Internal Medicine from Gauhati Medical College, and DM in Clinical Hematology from AIIMS, New Delhi.
His clinical and research interests include plasma cell disorders, bone marrow transplantation, and innovative cellular therapies such as CAR-T cell therapy. Before joining Rajagiri Hospital, Dr. Kumar led the Myeloma and Amyloidosis program at Fortis Memorial Research Institute, Gurugram.
He has co-authored multiple peer-reviewed publications in national and international journals and served as a co-investigator in landmark trials like MAJESTEC-9, MonumenTAL6, and the DRL1801 CAR-T trial. Dr. Kumar has presented extensively at international and national conferences on emerging areas in multiple myeloma, transplant, and immunotherapy.
er, and academic leader with expertise in bone marrow transplantation and cellular therapies. She is the current President of the Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) society and a 2025 Fulbright Senior Scholar.
Her research focuses on improving access and outcomes in advanced therapies, including CAR-T and allogeneic transplant, with a strong emphasis on equity, real-world data, and health system innovation. She leads national and international collaborations that integrate clinical care, research, and policy to address disparities in complex care.
Prof Hamad supervises ILP, Honours, and HDR students across projects spanning translational haematology, equity in access to care, and system-level reform. She is committed to mentorship, capacity building, and supporting the next generation of clinician-scientists.
Her work is supported through government, philanthropic, and industry partnerships aimed at driving meaningful change in health outcomes and health equity.
Nikhil M. Kumar
Kochi, India
Peihua (Peggy) Lu
Chairperson of the Board Executive Director and Medical Executive President Lu Daopei Medical Group, Beijing, China Peking University Medical School Residency training, University of Nebraska Medical Center, USA Hematology/oncology fellowship, Stanford University Medical Center, USA
Dr. Lu has extensive experience in CAR-T immunotherapy and has led multiple CAR-T clinical trials in Lu Daopei hospital since 2015.
Peihua (Peggy) Lu
USA
Rajat Bhattacharyya
Senior Consultant Paediatric Haematology Oncology and Stem Cell Transplant Apollo Multispeciality Hospital, Kolkata India
Rajat Bhattacharyya
Kolkata India
Sathish Kumar A
Manipal Hospital, Yeshwanthpur Consultant Clinical Hematologist & Hemato-Oncologist Bangalore, India
DM in Clinical Hematology from KEM Hospital, Mumbai
Fellowship in Leukemia and Bone Marrow Transplantation at Vancouver, Canada
Consultant Hematologist, Haemato-oncologist and BMT Physician, Manipal Hospitals, Bangalore (Yeshwnatpur, Millers Road, and Hebbal)
Author and co-author of publications in multiple National and International journals
Sathish Kumar A
Bengaluru, India
Stalin Ramprakash
Aster CMI hospital ( Aster group of hospitals, Bengaluru) city & country- Bengaluru, India
Stalin Ramprakash
Bengaluru, India
Stephan Kadauke, MD, PhD
Stephan Kadauke, MD, PhD, is the Associate Director of the Cell Based Therapy Laboratory and the Medical Director of Cell and Gene Therapy Informatics at Children's Hospital of Philadelphia, USA Areas of expertise: CAR T cell therapy, Gene therapy, Transfusion medicine, Apheresis, Pediatric transfusion management, Sickle cell disease
Stephan Kadauke, MD, PhD
Philadelphia, USA
Veerendra Patil
Senior Consultant Paediatric Oncologist haematologist and BMT Physician Basavatarakam Indo-American Cancer hospital and research Institute Hyderabad
Veerendra Patil
Hyderabad, India
Bala Stalin Chowdary
Visakhapatnam, India
Chief Medical and Hemato-Oncologist
BMT and Cellular therapy Physician
Mahatma Gandhi Cancer Hospital
Visakhapatnam, India
Bala Stalin Chowdary
Visakhapatnam, India